Inflammatory Origins of CRS: Uncovering Opportunities for Disease Prevention and Modification
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 408B
2.50 CME/CE
David W. Hauswirth , MD FAAAAI

Learning Objectives:
  1. Describe the role of the microbiome and biofilms in the development of CRS
  2. Discuss the implications of antibiotic use and overuse in CRS
  3. Identify inflammatory pathways in CRS and opportunities for disease modification
10:00 AM
The Role of Biofilms and the Microbiome in the Development of CRS
Robert C. Kern, MD
10:30 AM
Negative Effects of Antibiotics in Origins of CRS
Martin Wagenmann, MD FAAAAI
11:00 AM
Question & Answer Panel Discussion
11:15 AM
Antibody Deficiency: Epidemiological, Clinical and Pathological Overlap with CRS
Anju T. Peters, MD FAAAAI
11:45 AM
Biologics in Chronic Rhninosinusitis with Nasal Polyps: Current State and Future Role
Claus Bachert, MD PhD
  • Biologics JACI 2015.pdf (1.6 MB)
  • 12:15 PM
    Question & Answer Panel Discussion
    See more of: Session